IN2014KN01420A - - Google Patents

Info

Publication number
IN2014KN01420A
IN2014KN01420A IN1420KON2014A IN2014KN01420A IN 2014KN01420 A IN2014KN01420 A IN 2014KN01420A IN 1420KON2014 A IN1420KON2014 A IN 1420KON2014A IN 2014KN01420 A IN2014KN01420 A IN 2014KN01420A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Xiaoqing Qiu
Original Assignee
Protein Design Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protein Design Lab Ltd filed Critical Protein Design Lab Ltd
Publication of IN2014KN01420A publication Critical patent/IN2014KN01420A/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081DNA viruses
    • C07K16/085Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Gram-negative bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00725Peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
IN1420KON2014 2011-12-08 2014-07-04 IN2014KN01420A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201110405775 2011-12-08
PCT/CN2012/086296 WO2013083095A1 (zh) 2011-12-08 2012-12-10 一种制备新型抗生素的方法及依据该方法的平台系统

Publications (1)

Publication Number Publication Date
IN2014KN01420A true IN2014KN01420A (he) 2015-10-23

Family

ID=48573572

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1420KON2014 IN2014KN01420A (he) 2011-12-08 2014-07-04

Country Status (20)

Country Link
US (1) US10071358B2 (he)
EP (1) EP2789632B1 (he)
JP (2) JP2015507471A (he)
KR (2) KR101916205B1 (he)
CN (1) CN103159856B (he)
AP (1) AP2014007769A0 (he)
AU (1) AU2012349080B2 (he)
BR (1) BR112014013735A2 (he)
CA (1) CA2857976A1 (he)
CO (1) CO7101191A2 (he)
DK (1) DK2789632T3 (he)
EA (1) EA201400634A1 (he)
ES (1) ES2686341T3 (he)
IL (1) IL232995B (he)
IN (1) IN2014KN01420A (he)
PH (1) PH12014501276A1 (he)
SG (1) SG11201402990YA (he)
TW (1) TWI557225B (he)
WO (1) WO2013083095A1 (he)
ZA (1) ZA201404527B (he)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9200251B1 (en) 2011-03-31 2015-12-01 David Gordon Bermudes Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith
CN102747041B (zh) * 2011-04-21 2014-07-16 畿晋庆三联(北京)生物技术有限公司 抗蓝藻重组抗体多肽及其基因与制备方法
CN108341869A (zh) * 2016-12-26 2018-07-31 畿晋庆三联(北京)生物技术有限公司 抗结核分枝杆菌(Mycobacterium tuberculosis)及其感染的药物及其应用
US11125750B2 (en) * 2018-06-28 2021-09-21 The University Of Toledo Methods, assays and kits for detecting exposure to cyanotoxins
CN119943165A (zh) * 2024-05-10 2025-05-06 中国人民解放军军事科学院军事医学研究院 一种病原微生物数据库及其构建方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1274829C (zh) 2004-12-10 2006-09-13 四川大学华西医院 抗eb病毒所致肿瘤多肽及其应用与制备方法
DE102007036128A1 (de) * 2007-07-23 2009-02-12 Universität Leipzig Antibiotische Peptide
CN101200727B (zh) 2007-12-21 2013-06-26 畿晋庆堂国际生物技术有限公司 抗农作物真菌多肽及其制备方法
CN101215568B (zh) * 2008-01-18 2010-06-23 畿晋庆三联(北京)生物技术有限公司 抗炭疽多肽及其应用与制备方法
CN101643501B (zh) * 2008-11-07 2012-06-20 畿晋庆三联(北京)生物技术有限公司 一种新型抗生素及其核苷酸序列、制备方法与应用
CN101633699B (zh) * 2009-09-02 2012-02-15 畿晋庆堂国际生物技术有限公司 一种含抗体模拟物的新型抗生素及其制备方法与应用
CN102101888B (zh) * 2009-12-17 2013-03-20 畿晋庆三联(北京)生物技术有限公司 一种新型抗eb病毒所致肿瘤多肽及其应用与制备方法
CN102747041B (zh) 2011-04-21 2014-07-16 畿晋庆三联(北京)生物技术有限公司 抗蓝藻重组抗体多肽及其基因与制备方法

Also Published As

Publication number Publication date
KR20140104475A (ko) 2014-08-28
HK1197247A1 (en) 2015-01-09
WO2013083095A1 (zh) 2013-06-13
PH12014501276A1 (en) 2014-09-08
AP2014007769A0 (en) 2014-07-31
BR112014013735A2 (pt) 2017-06-13
US20140349880A1 (en) 2014-11-27
KR20160130531A (ko) 2016-11-11
AU2012349080A1 (en) 2014-07-24
ES2686341T3 (es) 2018-10-17
EP2789632A4 (en) 2015-07-22
JP2015507471A (ja) 2015-03-12
CO7101191A2 (es) 2014-10-31
JP2017023150A (ja) 2017-02-02
EA201400634A1 (ru) 2014-12-30
IL232995B (he) 2018-01-31
US10071358B2 (en) 2018-09-11
ZA201404527B (en) 2017-04-26
TW201331363A (zh) 2013-08-01
JP6412077B2 (ja) 2018-10-24
CN103159856A (zh) 2013-06-19
CA2857976A1 (en) 2013-06-13
EP2789632B1 (en) 2018-06-06
TWI557225B (zh) 2016-11-11
DK2789632T3 (en) 2018-08-06
NZ627116A (en) 2016-07-29
KR101916205B1 (ko) 2018-11-08
CN103159856B (zh) 2015-02-25
EP2789632A1 (en) 2014-10-15
SG11201402990YA (en) 2014-09-26
IL232995A0 (he) 2014-07-31
AU2012349080B2 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
BR112013022641A2 (he)
BR112013031251A2 (he)
BR112013027245A2 (he)
BR112013024383A2 (he)
BR112013026905A2 (he)
BR112013023185A2 (he)
BR112013022995A2 (he)
BR112013017670A2 (he)
BR112013027830A2 (he)
BR112013026744A2 (he)
AP3853A (he)
BR112013023927A2 (he)
BR112013027452A2 (he)
BR112013024365A2 (he)
BR112013027121A2 (he)
BR112013031556A2 (he)
BR112013026790A2 (he)
BR112013024588A2 (he)
BR112013032366A2 (he)
BR112013032377A2 (he)
BR112013032380A2 (he)
BR112013027836A2 (he)
BR112013026895A2 (he)
BR112013018949A2 (he)
BR112013027761A2 (he)